Anchored by TV spots and sports media placements, the Every Inch Matters campaign positions the projected number one overall ...

Pfizer has abandoned work on a PD-L1-targeting drug that was being tested in patients with various cancers. | Pfizer has ...

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2026 dividend on the ...

Pfizer has a higher-yielding dividend, but it may not be safe. AbbVie has the better path to growth in 2026. But when you ...

If the crackdown on pharma’s TV ads and subsequent extension to social media has underscored anything, it’s that brands need ...

Pfizer (PFE) stock is in focus as executive Andrew Baum, who joined the company in 2024 as the Chief Strategy and Innovation ...

Pfizer continues delivering consistent earnings beats, driven by cost-cutting initiatives and improving margins. Learn more ...

The latest trading day saw Pfizer (PFE) settling at $26.8, representing a -1.87% change from its previous close.

Pfizer’s GLP-1 weight management treatment Xianweiying, is reportedly available for pre-order in China in the wake of ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

Pharmaceutical company Pfizer is planning to cut around 100 jobs at its plant in Ringaskiddy, Co Cork. The company. "Pfizer ...

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.